S.01913

Relates to establishing the "340B prescription drug anti-discrimination act"; prohibits pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on participation in the drug discount program authorized by section 340B of the federal public health service act.

Chamber Passed·6/4/26
Introduced Text

New York S01913 establishes the "340B prescription drug anti-discrimination act" to prevent discrimination against covered entities and New York.

New York S01913, the "340B prescription drug anti-discrimination act," aims to prohibit pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on their participation in the federal drug discount program authorized by section 340B of the federal public health service act. The act bans practices such as limiting drug dispensing, denying access to drugs, or imposing different conditions on participating entities.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the Senate · 48–12 · Jun 4
Current
Health Committee
Next
House floor vote

Sponsors

DDDDDDDDDDDDDDDDDDDDDDD
23
0
Democratic CaucusRepublican Caucus

Roll Call Votes

48 Yea

DDRDDDDRRDDDRRDDDDDDDDDDDDDDDRRDDDDRDDRDDDDDDRDD

12 Nay

RRRRRRRRRRRR

3 Absent

DDD

Calendar

Mar 24

11:00 AM

Senate Finance Committee Hearing

Jan 27

12:00 AM

Senate Health Committee Hearing

History

Jun 5

Assembly

referred to health

Jun 4

Senate

PASSED SENATE

Jun 4

Senate

DELIVERED TO ASSEMBLY